| 摘要 |
The use of aequorin in the manufacture of a composition for preventing or alleviating a symptom or disorder associated with calcium imbalance in a subject is disclosed, wherein the symptom or disorder associated with calcium imbalance may be related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion or bone mineralization, and wherein the symptom or disorder may be caused by ischemia. In such compositions aequorin can also be provided in combination with an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof.
|
